Immune Pharmaceuticals Inc buy melinda
Start price
31.08.17
/
50%
€1.12
Target price
19.12.17
€1.80
Performance (%)
-50.12%
End price
19.12.17
€0.56
Summary
This prediction ended on 19.12.17 with a price of €0.56. Massive losses of -50.12% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immune Pharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | 4.094% | 3.543% | 17.404% | 20.326% |
| iShares Nasdaq 100 | 1.424% | 0.512% | 39.212% | 55.365% |
| iShares Nikkei 225® | -1.572% | -4.633% | 15.731% | 2.146% |
| iShares S&P 500 | 1.822% | 0.963% | 30.396% | 45.950% |
Comments by melinda for this prediction
In the thread Immune Pharmaceuticals Inc diskutieren
Gesundheit | Hersteller von Medikamenten - Erhebliche | Vereinigte Staaten
Über Immune Pharmaceuticals Inc.
Immune Pharmaceuticals Inc. (imnp) Wendet einen personalisierten Ansatz zur Behandlung und entwickeln neue zielgerichtete Therapien gegen das Leben von Patienten mit entzündlichen Erkrankungen und Krebs zu verbessern
(Vom Mitglied beendet)
Stopped prediction by melinda for Immune Pharmaceuticals Inc
Immune Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.002
27.07.20
27.07.20
€0.050
04.11.21
04.11.21
42.86%
05.11.21
05.11.21
Immune Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.24
31.08.17
31.08.17
€2.00
19.12.17
19.12.17
-50.12%
19.12.17
19.12.17